双氯芬胺
- 价格： ￥99/瓶
- 发布日期： 2019-04-01
- 更新日期： 2025-02-28
产品详请
| 产地 |
加拿大
|
| 品牌 |
进口
|
| 货号 |
04-436530
|
| 英文名称 |
Diclofenamide
|
| 包装规格 |
50mg，500mg
|
| 纯度 |
98%
|
| CAS编号 |
120-97-8
|
| 别名 |
1,3-Disulfamoyl-4,5-dichlorobenzene; 1,3-Disulfamyl-4,5-dichlorobenzene; 3,4-Dichloro-5-sulfamylbenzenesulfonamide; 4,5-Dichloro-1,3-disulfamoylbenzene; 4,5-Dichloro-m-benzenedisulfonamide; Antidrasi; CB 8000; Daramide; Daranide; Dichlofenamide; Dichlorophenamide; Dichlorphenamide; Diclofenamid; Glaucol; Oratrol;
|
| 分子式 |
C6H6Cl2N2O4S2
|
货号：04-436530
中文名称：双氯芬胺
英文名称：Diclofenamide-13C6
CAS号：120-97-8
重量：50mg
重量：500mg
分子式：C6H6Cl2N2O4S2
别名：1,3-Disulfamoyl-4,5-dichlorobenzene; 1,3-Disulfamyl-4,5-dichlorobenzene; 3,4-Dichloro-5-sulfamylbenzenesulfonamide; 4,5-Dichloro-1,3-disulfamoylbenzene; 4,5-Dichloro-m-benzenedisulfonamide; Antidrasi; CB 8000; Daramide; Daranide; Dichlofenamide; Dichlorophenamide; Dichlorphenamide; Diclofenamid; Glaucol; Oratrol;
应用介绍：Diclofenamide is a potent carbonic anhydrase inhibitor. Diclofenamide may provide a therapeutic strategy in the inhibition of the human cytosolic isoforms I and II and transmembrane tumor-associated isoenzymes IX and XII. Diclofenamide has been shown to be is effective in the prevention of episodic weakness in both hypokalemic periodic paralysis (HypoPP) and potassium-sensitive periodic paralysis (PSPP).
